Alexander Raven

Alexander Raven

Auto-generated profile, based on publicly available information

Alexander Raven

Cancer Research UK Scotland Institute, Glasgow, UK

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2017 in Nature
Verified
Journal Article
Open access
PDF file
ARAlexander Raven
Alexander Raven
WLWei-Yu Lu
Wei-Yu Lu
TMTak Yung Man
Tak Yung Man
SFSofia Ferreira-Gonzalez
Sofia Ferreira-Gonzalez
EOEoghan O’dUibhir
Eoghan O’dUibhir
SFStuart J. Forbes
Stuart J. Forbes
Two independent systems impairing hepatocyte proliferation during liver injury cause physiologically significant levels of functional hepatocyte regeneration from biliary cells. Liver injury triggers regeneration through proliferation of hepatocytes to compensate for the loss of cells. However, in humans, this process is impaired in chronic liver diseases and it has been difficult to reproduce this impairment in mouse models of liver injury. Stuart Forbes and colleagues have used two systems to impair hepatocyte proliferation, via impairment of β-integrin or overexpression of the cell cycle inhibitor p21. They observe that, following injury under these conditions, epithelial bile duct cells are able to adopt hepatic fate and regenerate up to 25% of functional hepatocytes. After liver injury, regeneration occurs through self-replication of hepatocytes. In severe liver injury, hepatocyte proliferation is impaired—a feature of human chronic liver disease1,2. It is unclear whether other liver cell types can regenerate hepatocytes3,4,5. Here we use two independent systems to impair hepatocyte proliferation during liver injury to evaluate the contribution of non-hepatocytes to parenchymal regeneration. First, loss of β1-integrin in hepatocytes with liver injury triggered a ductular reaction of cholangiocyte origin, with approximately 25% of hepatocytes being derived from a non-hepatocyte origin. Second, cholangiocytes were lineage traced with concurrent inhibition of hepatocyte proliferation by β1-integrin knockdown or p21 overexpression, resulting in the significant emergence of cholangiocyte-derived hepatocytes. We describe a model of combined liver injury and inhibition of hepatocyte proliferation that causes physiologically significant levels of regeneration of functional hepatocytes from biliary cells.

14 March 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
SRShantisree Sandeepani Rayagiri
Shantisree Sandeepani Rayagiri
DRDaniele Ranaldi
Daniele Ranaldi
ARAlexander Raven
Alexander Raven
NANur Izzah Farhana Mohamad Azhar
Nur Izzah Farhana Mohamad Azhar
OLOlivier Lefebvre
Olivier Lefebvre
ABAnne-Gaëlle Borycki
Anne-Gaëlle Borycki
A central question in stem cell biology is the relationship between stem cells and their niche. Although previous reports have uncovered how signaling molecules released by niche cells support stem cell function, the role of the extra-cellular matrix (ECM) within the niche is unclear. Here, we show that upon activation, skeletal muscle stem cells (satellite cells) induce local remodeling of the ECM and the deposition of laminin-α1 and laminin-α5 into the basal lamina of the satellite cell niche. Genetic ablation of laminin-α1, disruption of integrin-α6 signaling or blocking matrix metalloproteinase activity impairs satellite cell expansion and self-renewal. Collectively, our findings establish that remodeling of the ECM is an integral process of stem cell activity to support propagation and self-renewal, and may explain the effect laminin-α1-containing supports have on embryonic and adult stem cells, as well as the regenerative activity of exogenous laminin-111 therapy.

9 March 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
SFSofia Ferreira-Gonzalez
Sofia Ferreira-Gonzalez
WLWei-Yu Lu
Wei-Yu Lu
ARAlexander Raven
Alexander Raven
BDBenjamin Dwyer
Benjamin Dwyer
TMTak Yung Man
Tak Yung Man
SFStuart J. Forbes
Stuart J. Forbes
Cellular senescence is a mechanism that provides an irreversible barrier to cell cycle progression to prevent undesired proliferation. However, under pathological circumstances, senescence can adversely affect organ function, viability and regeneration. We have developed a mouse model of biliary senescence, based on the conditional deletion of Mdm2 in bile ducts under the control of the Krt19 promoter, that exhibits features of biliary disease. Here we report that senescent cholangiocytes induce profound alterations in the cellular and signalling microenvironment, with recruitment of myofibroblasts and macrophages causing collagen deposition, TGFβ production and induction of senescence in surrounding cholangiocytes and hepatocytes. Finally, we study how inhibition of TGFβ-signalling disrupts the transmission of senescence and restores liver function. We identify cellular senescence as a detrimental mechanism in the development of biliary injury. Our results identify TGFβ as a potential therapeutic target to limit senescence-dependent aggravation in human cholangiopathies.

10 October 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
RGRachel V. Guest
Rachel V. Guest
LBLuke Boulter
Luke Boulter
BDBenjamin J. Dwyer
Benjamin J. Dwyer
Tim KendallTim Kendall
Tim Kendall
TMTak-Yung Man
Tak-Yung Man
SFStuart J. Forbes
Stuart J. Forbes
Significance: Clinical outcomes in cholangiocarcinoma (CC) are poor; few patients are candidates for curative resection, and palliative chemotherapy produces only modest effects on survival. With an increasing incidence, new targets are urgently needed. Notch has been identified as having potential to induce CC when transgenically overexpressed, and this study aimed to characterize how endogenous Notch might drive tumorigenesis. We identify the atypical receptor Notch3 as differentially overactivated in CCs in humans, rats, and mice, with genetic deletion significantly reducing CC growth. Notch3 sustains tumor cell survival through PI3k/Akt activation via a noncanonical mechanism independent of Recombinant Signal Binding Protein for Immunoglobulin Kappa J Region (RBPJ), presenting an opportunity to target the pathway without disrupting classical Notch and bypassing toxicities associated with γ-secretase inhibitors.

24 November 2025 in Nature
Verified
Journal Article
Open access
PDF file
MWMark White
Mark White
MMMegan L. Mills
Megan L. Mills
LMLaura M. Millett
Laura M. Millett
KGKathryn Gilroy
Kathryn Gilroy
YHYourae Hong
Yourae Hong
OSOwen Sansom
Owen Sansom
The colorectal epithelium is rapidly renewing, with remarkable capacity to regenerate following injury. In colorectal cancer (CRC), this regenerative capacity can be co-opted to drive epithelial plasticity. Although oncogenic MAPK signalling in CRC is common, with frequent mutations of both KRAS (40–50%) and BRAF (10%) 1 , inhibition of this pathway typically drives resistance clinically. Here, given the development of KRAS inhibitors and licensing of BRAF inhibitor combinations 2–4 , we have interrogated key mechanisms of resistance to these agents in advanced preclinical CRC models. We show that oncogenic MAPK signalling induces epithelial-state changes in vivo, driving adoption of a regenerative/revival stem-like population, whereas inhibition leads to rapid transcriptional remodelling of both Kras -mutant and Braf- mutant tumours, favouring a WNT-associated, canonical stem phenotype. This drives acute therapeutic resistance in Kras -driven and delayed resistance in Braf -driven models. Where plasticity is restrained, such as in early metastatic disease, or through targeting ligand-dependent WNT pathway Rnf43 mutations, marked therapeutic responses are observed. This explains the super response to BRAF + EGFR-targeted therapies previously observed in a BRAF–RNF43 co-mutant patient population, highlighting the criticality of cellular plasticity in therapeutic response. Together, our data provide clear insight into the mechanisms underpinning resistance to MAPK-targeted therapies in CRC. Moreover, strategies that aim to corral stem cell fate, restrict epithelial plasticity or intervene when tumours lack heterogeneity may improve therapeutic efficacy of these agents.

19 November 2021 in Science Advances
Verified
Journal Article
Open access
SHSarika Heino
Sarika Heino
SFShentong Fang
Shentong Fang
MLMarianne Lähde
Marianne Lähde
JHJenny Högström
Jenny Högström
SNSina Nassiri
Sina Nassiri
KAKari Alitalo
Kari Alitalo
Lef1 is induced in intestinal adenomas, in which it restricts ectopic crypt formation and tumor growth.